The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Artipla Meds for Co-Infection Patient
May 11, 2009

I am planning on starting my treatment and am concerned about my liver and want to make sure that I take the correct meds. My Dr. wants to start me on Atripia. Is this the best med for HCV patient or is there a beter mix of meds to start with.


Response from Dr. McGowan

Thank you for your question. I have successfully used Atripla (Tenofovir/FTC/efavirenz) in many patients who are co-infected with Hepatitis C. It is probably the combination of choice in patient initiating treatment for their HIV who also have Hepatitis B infection. In any patient but in particular patients who have active liver disease, I follow for signs, symptoms and laboratory values that might indicate an exacerbation of their hepatitis C infection. Obviously during the initial stages of treatment one needs to more vigilant. As to your question if Atripla is the best combination...this is hard to generalize. There are certain boosted protease inhibitors that I would avoid in patients with co-existing Hepatitis C infection but I do not have any single preferred regimen like Atripla.


  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint